Cold Spring Harbor Laboratory’s Dr. Mikala Egeblad has received a $60,000 grant from the Katie Oppo Research Foundation (KORF) to support her work in metastatic ovarian cancer – a disease that is often difficult to treat. In collaboration with Northwell Health, the Egeblad lab is targeting macrophages – a type of immune cells: Macrophages classically have tumor promoting functions, but Dr. Egeblad’s lab has developed an approach to reprogram the macrophages so they become tumoricidal. Dr. Egeblad hopes this project eventually will lead to new types of therapies and a better outcome for ovarian cancer patients. This is the second grant Dr. Egeblad has received from KORF to support this work.
About the Katie Oppo Research Foundation – KORF’s mission is to increase awareness and fund research for the prevention, treatment, and cure of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) – a rare and life-threatening disease–as well as all forms of ovarian cancer.